CYP3A4

Uses your system voice; voice and rate in settings.

Snapshot

≈ 6 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Cytochrome P450 3A4 (abbreviated CYP3A4) ( ) is an important enzyme in the body, mainly found in the liver and the intestine. In humans is encoded by CYP3A4 gene. It oxidizes small foreign organic molecules (xenobiotics), such as toxins or drugs, so that they can be removed from the body. The enzyme is highly homologous to CYP3A5, another important CYP3A enzyme. While many drugs are deactivated by CYP3A4, there are also some drugs that are activated by the enzyme.

Some substances, such as some drugs and furanocoumarins present in grapefruit juice, interfere with the action of CYP3A4. These substances will, therefore, either amplify or weaken the action of those drugs that are modified by CYP3A4. CYP3A4 is a member of the cytochrome P450 family of oxidizing enzymes. Several other members of this family are also involved in drug metabolism, but CYP3A4 is the most common and the most versatile one. Like all members of this family, it is a hemoprotein, i.e. a protein containing a heme group with an iron atom.

In humans, the CYP3A4 protein is encoded by the CYP3A4 gene. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q22.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4.…

Cytochrome P450 3A4 (abbreviated CYP3A4) ( ) is an important enzyme in the body, mainly found in the liver and the intestine. In humans is encoded by CYP3A4 gene. It oxidizes small foreign organic molecules (xenobiotics), such as toxins or drugs, so that they can be removed from the body. The enzyme is highly homologous to CYP3A5, another important CYP3A enzyme. While many drugs are deactivated by CYP3A4, there are also some drugs that are activated by the enzyme.

Some substances, such as some drugs and furanocoumarins present in grapefruit juice, interfere with the action of CYP3A4. These substances will, therefore, either amplify or weaken the action of those drugs that are modified by CYP3A4. CYP3A4 is a member of the cytochrome P450 family of oxidizing enzymes. Several other members of this family are also involved in drug metabolism, but CYP3A4 is the most common and the most versatile one. Like all members of this family, it is a hemoprotein, i.e. a protein containing a heme group with an iron atom.

In humans, the CYP3A4 protein is encoded by the CYP3A4 gene. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q22.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively-spliced transcript variants encoding different isoforms have been identified.

Turnover

Estimates of the turnover rate of human CYP3A4 vary widely. For hepatic CYP3A4, in vivo methods yield estimates of the enzyme half-life mainly in the range of 70 to 140 hours, whereas in vitro methods give estimates from 26 to 79 hours. Turnover of gut CYP3A4 is likely to be a function of the rate of enterocyte renewal; an indirect approach based on the recovery of activity following exposure to grapefruit juice yields measurements in the 12- to 33-hour range.

Technology

Due to membrane-bound CYP3A4's natural propensity to conglomerate, it has historically been difficult to study drug binding in both solution and on surfaces. Co-crystallization is difficult since the substrates tend to have a low K D (between 5–150 μM) and low solubility in aqueous solutions. A successful strategy in isolating the bound enzyme is the functional stabilization of monomeric CYP3A4 on silver nanoparticles produced from nanosphere lithography and analyzed via localized surface plasmon resonance spectroscopy (LSPR). These analyses can be used as a high-sensitivity assay of drug binding, and may become integral in further high-throughput assays utilized in initial drug discovery testing. In addition to LSPR, CYP3A4-Nanodisc complexes have been found helpful in other applications including solid-state NMR, redox potentiometry, and steady-state enzyme kinetics.

Strong inhibitors

boceprevir, protease inhibitors: ritonavir, indinavir, nelfinavir, saquinavir; some macrolide antibiotics: clarithromycin, erythromycin (although FDA lists it as a moderate inhibitor, and inhibitor of P-glycoprotein, defined as those increasing the AUC of digoxin to ≥1.25-fold); telithromycin ceritinib mibefradil (used for the treatment of hypertension and chronic angina pectoris) nefazodone (antidepressant) ribociclib tucatinib chloramphenicol (antibiotic) some azole antifungals: ketoconazole, itraconazole, posaconazole, voriconazole; cobicistat, green tea extract, grape seed extract, dillapiole (compound present in dill plants), apigenin (compound present in plants such as celery, parsley, and chamomile) Artemisia annua

Moderate inhibitors

amiodarone (class III antiarrhythmic), aprepitant, (antiemetic) ciprofloxacin, conivaptan, crizotinib, rutin (in vitro) (dietary flavonoid), tofisopam, some calcium channel blockers: verapamil, diltiazem; some azole antifungals: fluconazole, miconazole; bergamottin (constituent of grapefruit juice), cyclosporine, donedarone, fluvoxamine, imatinib, valerian.

Weak inhibitors

berberine (an alkaloid found in plants such as berberis or goldenseal), buprenorphine (analgesic), cafestol (in unfiltered coffee) cilostazol, cimetidine, fosaprepitant, lomitapide, orphenadrine, omeprazole (proton pump inhibitor), quercetin, ranitidine, ranolazine, tacrolimus, ticagrelor, valproic acid, amlodipine, azithromycin (macrolide antibiotic).

Inhibitors of unspecified potency

bergaptol (a furocoumarin in citrus), cannabidiol, dithiocarbamate (functional group), flavonoids, mifepristone (abortifacient), norfloxacin (fluoroquinolone antibiotic), some non-nucleoside reverse-transcriptase inhibitors: delavirdine; gestodene (hormonal contraceptive), star fruit, milk thistle, niacin (nicotinic acid) and its form – niacinamide (nicotinamide), collectively called as Vitamin B 3 , ginkgo biloba, sesamin (a lignan constituent in sesame seeds and oil), piperine, isoniazid, serenoa, phenelzine (weak, irreversible inhibitor in vitro; clinical potency unestablished) .

Strong inducers

carbamazepine, antiandrogens: enzalutamide, apalutamide; primidone phenytoin (anticonvulsant), rifampin.

Weak inducers

upadacitinib.

Inducers of unspecified potency

anticonvulsants, mood stabilizers: oxcarbazepine, topiramate; barbiturates: phenobarbital, butalbital: St. John's wort, some bactericidals: rifampicin, rifabutin; some non-nucleoside reverse-transcriptase inhibitors: efavirenz, nevirapine; troglitazone (hypoglycemic), glucocorticoids (blood glucose increase, immunosuppressive), modafinil (stimulant), capsaicin, brigatinib, clobazam, dabrafenib, elagolix, eslicarbazepine, letermovir, lorlatinib, oritavancin, perampanel, telotristat.

Interactive pathway map

Text derived from https://en.wikipedia.org/w/index.php?oldid=1376279903 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

20 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.